TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014
TCL Archive Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied July 17, 1992